We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$483M
AUM Growth
+$12.7M
Cap. Flow
-$7.77M
Cap. Flow %
-1.61%
Top 10 Hldgs %
17.02%
Holding
376
New
4
Increased
1
Reduced
1
Closed
10

Top Buys

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$404K
2
RIGL icon
Rigel Pharmaceuticals
RIGL
+$287K
3
DELL icon
Dell
DELL
+$271K
4
CVG
Convergys
CVG
+$213K
5
MAN icon
ManpowerGroup
MAN
+$207K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.69M
2
EMC
EMC CORPORATION
EMC
+$1.36M
3
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$1.33M
4
MDVN
MEDIVATION, INC.
MDVN
+$1.21M
5
ALK icon
Alaska Air
ALK
+$1.17M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 14.81%
3 Healthcare 13.75%
4 Industrials 11.98%
5 Consumer Staples 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXPE icon
276
Expedia Group
EXPE
$35.4B
$452K 0.09%
3,875
– –
XRX icon
277
Xerox
XRX
$387M
$446K 0.09%
16,698
– –
HIG icon
278
Hartford Financial Services
HIG
$38.9B
$428K 0.09%
10,000
– –
TIVO
279
DELISTED
Tivo Inc
TIVO
$424K 0.09%
21,758
– –
ABT icon
280
Abbott
ABT
$183B
$423K 0.09%
10,000
– –
PEG icon
281
Public Service Enterprise Group
PEG
$38.2B
$419K 0.09%
10,000
– –
HRB icon
282
H&R Block
HRB
$5.58B
$417K 0.09%
18,000
– –
ARRY
283
DELISTED
Array Biopharma Inc
ARRY
$405K 0.08%
60,000
– –
CLDX icon
284
Celldex Therapeutics
CLDX
$2.99B
$404K 0.08%
6,667
– –
COR icon
285
Cencora
COR
$60.6B
$404K 0.08%
4,996
– –
KMI icon
286
Kinder Morgan
KMI
$71.7B
$399K 0.08%
17,265
– –
STJ
287
DELISTED
St Jude Medical
STJ
$399K 0.08%
+5,000
New +$404K
OA
288
DELISTED
Orbital ATK, Inc.
OA
$397K 0.08%
5,209
– –
C icon
289
Citigroup
C
$222B
$378K 0.08%
8,000
– –
M icon
290
Macy's
M
$6.53B
$371K 0.08%
10,000
– –
HAYN
291
DELISTED
Haynes International, Inc.
HAYN
$371K 0.08%
10,000
– –
DOV icon
292
Dover
DOV
$27.6B
$368K 0.08%
6,190
– –
KEYS icon
293
Keysight
KEYS
$54.5B
$366K 0.08%
11,542
– –
JNPR
294
DELISTED
Juniper Networks
JNPR
$361K 0.07%
15,000
– –
XRAY icon
295
Dentsply Sirona
XRAY
$2.68B
$357K 0.07%
6,000
– –
GHL
296
DELISTED
Greenhill & Co., Inc.
GHL
$354K 0.07%
15,000
– –
VWTR
297
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$354K 0.07%
30,000
– –
EXC icon
298
Exelon
EXC
$47.2B
$340K 0.07%
14,300
– –
TT icon
299
Trane Technologies
TT
$100B
$340K 0.07%
5,000
– –
ARQL
300
DELISTED
Arqule Inc
ARQL
$340K 0.07%
190,000
– –
10 11
12
13 14

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2016 Portfolio in Review

As of Q3 2016, NJ State Employees Deferred Compensation Plan held 376 positions worth $483M, up 2.7% from $471M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 3.7%. NJ State Employees Deferred Compensation Plan opened 4 new positions and exited 10, leaving the 376-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2016 buy was St Jude Medical: 5,000 shares worth $399K.
  • NJ State Employees Deferred Compensation Plan added most to Rigel Pharmaceuticals in Q3 2016, an estimated $287K increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2016 reduction was Sio Gene Therapies Inc. Common Stock, cutting an estimated $450K.
  • NJ State Employees Deferred Compensation Plan fully exited Biogen in Q3 2016, selling an estimated $1.69M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 17% of its $483M portfolio in Q3 2016.
  • NJ State Employees Deferred Compensation Plan opened 4 new positions and closed 10 in Q3 2016.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 2.7% quarter-over-quarter to $483M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2016, filed 21 Oct 2016.